Invitrogen™ ELISA kit of rat MMP-2

Ref.: BL-RE-090863Manufacturer ref.: ERA42RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.

MMPs (matricial metalloproteinase) are proteolytic enzymes that can degrade connective tissue components. MMPs have a common activation mechanism, a sequence of amino acids conserved in the area of the site.

Accession number
P33436
Dose range
0.614 to 150 ng/ml
Sensitivity of the dosage
0.6 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

MMPs (matricial metalloproteinase) are proteolytic enzymes that can degrade connective tissue components. MMPs have a common activation mechanism, a sequence of amino acids conserved in the area of the site.

MMPs (matricial metalloproteinase) are proteolytic enzymes that can degrade connective tissue components. MMPs have a common activation mechanism, a sequence of amino acids retained in the putative active metal binding site region and are inhibited by specific metalloproteinase tissue inhibitors (TIMPs). MPMs and TIMPs play an important role in regulating angiogenesis. MMP2 is synthesized as a 631 amino acid proenzyme activated by cleavage of the first 80 amino acids and contains the basic structure of the propeptide, catalyst, and hemopexin domains. Matrix metalloproteinases (MMPs) are a family of at least eighteen secreted membrane-bound zincendopeptidases. Collectively, these enzymes can degrade all components of the extracellular matrix, including fibrillar and non-fibrillar collagens, fibronectin, laminine, and basal membrane glycoproteins. In general, a signal peptide, propeptide, and catalytic domain containing the highly conserved zinc binding site characterize the MMP structure. Functionally, MMP2 is involved in tissue remodeling. Mutations of the MMP-2 gene were associated with Winchester syndrome and nodulosis-arthropathy-osteolysis (NAO) syndrome. Two transcription variants coding for different isoforms of MMP-2 were found.

Sensitivity

Sensitivity of dosage: 0.6 ng/ml.

Measurement range

Dose range: 0.614 to 150 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: MMP2.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17778213
Specifications
Accession numberP33436
Dose range0.614 to 150 ng/ml
Sensitivity of the dosage0.6 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)81686
Gene symbol(s)MMP2
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetMMP2
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 μl-Plasma, 50 μl-Sera, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ERA42RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.